Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0038389992
Thu, 17.03.2022
BB BIOTECH AG
Media release of March 17, 2022
Shareholders at BB Biotech AG's AGM vote in favor of all proposals, approve the dividend of CHF 3.85 per share and elect two new board members
All proposals of BB Biotech AG's Board of Directors were approved by BB Biotech AG's shareholders at its Annual General Meeting held today.
Shareholders voted in favor of t [ … ]
Fri, 18.02.2022
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 of the SIX Listing Rules
February 18, 2022
Annual report of BB Biotech AG as at December 31, 2021
BB Biotech AG publishes its 2021 annual report
BB Biotech AG published its annual report for fiscal year 2021 today. Besides the audited consolidated financial statements, the annual report contains detailed i [ … ]
Fri, 18.02.2022
BB BIOTECH AG
Media release as at February 18, 2022
Annual report of BB Biotech AG as at December 31, 2021
BB Biotech AG publishes its 2021 annual report
BB Biotech AG published its annual report for fiscal year 2021 today. Besides the audited consolidated financial statements, the annual report contains detailed information on the biotechnology sector, BB Bi [ … ]
Fri, 21.01.2022
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 of the SIX Listing Rules
January 21, 2022
BB Biotech AG closes the 2021 fiscal year with a loss
In accordance with regulations on ad hoc publicity, BB Biotech AG (ISIN CH0038389992) is releasing the following information about its results for its financial year 2021.
Based on its preliminary unaudited cons [ … ]
Fri, 21.01.2022
BB BIOTECH AG
Media release as at January 21, 2022
Portfolio of BB Biotech AG as at December 31, 2021
2021 was a difficult year for biotech equity markets - increased dividend of CHF 3.85 proposed
The year 2021 was a volatile market environment for all involved in biotechnology investing, including BB Biotech. The biotech and pharmaceutical sector adapted to [ … ]
Fri, 22.10.2021
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 of the SIX Listing Rules
October 22, 2021
BB Biotech AG publishes its interim report
BB Biotech AG (ISIN CH0038389992) today published its interim report as at September 30, 2021, which covers the results of its business activities for the first nine months of 2021.
Based on the consolidated accounts of B [ … ]
Fri, 22.10.2021
BB BIOTECH AG
Media release of October 22, 2021
Interim report of BB Biotech AG as at September 30, 2021
BB Biotech: Gains realized following COVID-19 vaccine booster update enable increases in oncology and CNS
Healthcare markets traded higher in July and August but lost ground in September and ended the third quarter in line with the broader market. BB Biote [ … ]
Fri, 23.07.2021
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 of the SIX Listing Rules
July 23, 2021
BB Biotech AG publishes its interim report
BB Biotech AG (ISIN CH0038389992) today published its interim report as at June 30, 2021, which covers the results of its business activities for the first six months of 2021.
Based on the consolidated accounts of BB Biotech [ … ]
Fri, 23.07.2021
BB BIOTECH AG
Media release of July 23, 2021
Interim report of BB Biotech AG as at June 30, 2021
Solid second quarter for the biotech industry - BB Biotech raised its allocation to promising small and mid capsInflation moved higher during the second quarter as the economic recovery gathered steam, triggering temporary outflows of investor capital from growth s [ … ]
Fri, 23.04.2021
BB BIOTECH AG
Media release of April 23, 2021
Interim report of BB Biotech AG as at March 31, 2021
Successful vaccination campaigns point the way out of the corona crisis - sector re-valuation used for portfolio investments
BB Biotech delivered positive results for the first quarter amid a market environment characterized by profit-taking in the healthcare se [ … ]